Prolanta

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameProlanta
Drug Alias Nameprolactin receptor antagonist (Oncolix)prolactin receptor antagonist/anti-HER2agent (Oncolix)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonistsProlactin receptor modulators
TargetsProlactin receptorReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsSolid tumoursUterine NeoplasmsOvarian Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOncolix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOncolix Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursUterine NeoplasmsOvarian Neoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A